Genevieve Bergendahl Selected Research

Neuroblastoma

10/2023	Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
9/2023	A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
11/2022	A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
1/2022	A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
12/2020	A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
1/2016	A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
6/2015	Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
1/2015	A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genevieve Bergendahl Research Topics

Disease

8	Neuroblastoma 10/2023 - 01/2015
7	Neoplasms (Cancer) 02/2024 - 06/2015
3	Medulloblastoma 09/2023 - 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Alveolar Rhabdomyosarcoma 01/2022
1	Carcinoma (Carcinomatosis) 01/2017
1	Choroid Plexus Carcinoma 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017

Drug/Important Bio-Agent (IBA)

2	Eflornithine (Ornidyl)FDA Link 10/2023 - 11/2022
2	RNA (Ribonucleic Acid)IBA 11/2022 - 06/2015
2	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 01/2016
1	Topotecan (Hycamtin)FDA LinkGeneric 09/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023
1	NifurtimoxIBA 09/2023
1	Neuropilin-1IBA 01/2022
1	TB-403IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	PlatinumIBA 12/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2016
1	PolyaminesIBA 01/2015

Therapy/Procedure

5	Therapeutics 02/2024 - 06/2015
2	Immunotherapy 11/2022 - 12/2020
1	Drug Therapy (Chemotherapy) 12/2021
1	Adjuvant Chemotherapy 01/2017